ProMIS Neurosciences
19 hedge funds and large institutions have $4.1M invested in ProMIS Neurosciences in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
27% more funds holding
Funds holding: 15 → 19 (+4)
2.57% less ownership
Funds ownership: 28.49% → 25.92% (-2.6%)
37% less capital invested
Capital invested by funds: $6.49M → $4.1M (-$2.39M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$34.6K |
| 2 |
GL
Graypoint LLC
Albany,
New York
|
+$28.8K |
| 3 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$16.9K |
| 4 |
HFS
Howard Financial Services
Dallas,
Texas
|
+$14.2K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$6.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$107K |
| 2 |
ABG
Ally Bridge Group
New York
|
-$82K |
| 3 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$42.6K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$16.4K |
| 5 |
HCM
Heights Capital Management
San Francisco,
California
|
-$12.9K |
PMN Hedge Fund Activity: Q2 2025 in Review
19 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q2 2025, worth a combined $4.1M — down 37% from $6.49M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PMN positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.6K. The largest seller was Armistice Capital, cutting an estimated $107K.
- 19 institutional investors held ProMIS Neurosciences (PMN) as of Q2 2025, up from 15 in Q1 2025.
- Funds reported $4.1M of ProMIS Neurosciences stock for Q2 2025, down 37% quarter-over-quarter.
- 6 funds opened new ProMIS Neurosciences positions in Q2 2025 and 2 closed out, a net change of +4 holders.
- The largest ProMIS Neurosciences buyer in Q2 2025 was Citadel Advisors, an estimated $34.6K added.
- The largest ProMIS Neurosciences seller in Q2 2025 was Armistice Capital, an estimated $107K sold.
Based on aggregated 13F filings for Q2 2025.